Fujifilm partnership with Cynata, Novartis looking at Mesoblast and now more pertinently for OCC shareholders Styker signing up with the University of Queensland. Each time I slightly raise my probability of a J&J partnership. I just can't see them wanting to leave ATI on the table for someone else to pick up:
"UQ will be looking to collaborate with Stryker across a range of areas, including the development of new bio-materials, orthopaedics, infection control, stem cell technologies, wound healing, medical imaging , digital health and tissue growth." (my embolden)
Stryker are probably the market leader in orthopedic products and that they've invested in stem-cell research in Oz will not be off JNJ's radar:
https://www.uq.edu.au/news/article/2021/10/partnership-ignites-new-medical-rd-lab
J&J Partnership, page-295
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
66.5¢ |
Change
-0.020(2.92%) |
Mkt cap ! $159.0M | |||
| Open | High | Low | Value | Volume |
| 67.0¢ | 67.0¢ | 65.0¢ | $245.7K | 371.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 15000 | 65.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 66.5¢ | 12621 | 2 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| OCC (ASX) Chart |